Positive data from Sanifit’s Phase 2b CaLIPSO trial of SNF472 published in Circulation

    NEXT STORY
    Oncology Venture reaches new development milestone with Dovitinib.
    PREV STORY
    Oncology Venture is streamlining its communications by publishing press releases in English only going forward.
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    GeoVax Strengthens Scientific Staff and Expertise

    ATLANTA, GA, Aug. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: ...

    author_avatar
    NASDAQ Market News

    Geron Continues to Build Senior Leadership of Its Development Team

    author_avatar
    NASDAQ Market News

    Patient recruitment completed for phase II trial with glepaglutide for treatment of short bowel syndrome

    Press release - No. 1/2017   Patient recruitment completed for phase II trial with ...

    author_avatar
    NASDAQ Market News